Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.

about

Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.

Item

http://www.wikidata.org/entity/Q41992358

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Hematopoietic stem cell transp ...... paradigm and novel therapies.

@en

type

Item

label

Hematopoietic stem cell transp ...... paradigm and novel therapies.

@en

prefLabel

Hematopoietic stem cell transp ...... paradigm and novel therapies.

@en

P1476

Hematopoietic stem cell transp ...... t paradigm and novel therapies

@en

P2093

B R Dey

http://www.w3.org/2001/XMLSchema#string

J Khosla

http://www.w3.org/2001/XMLSchema#string

T R Spitzer

http://www.w3.org/2001/XMLSchema#string

P2860

A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury

Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease.

Calpain activity in bone marrow transplant-associated thrombotic thrombocytopenic purpura.

Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement.

A case of hemolytic uremic syndrome improved with nitric oxide.

Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.

Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes.

Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy.

Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT).

Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentiation of calcineurin-inhibitor-induced endothelial damage?

P2888

bmt.2017.207

P304

129-137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2017.207

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Albert C Yeh

P577

2017-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092056046

http://www.w3.org/2001/XMLSchema#string

P698

28967899

http://www.w3.org/2001/XMLSchema#string